Sandoz Group AG (OTCMKTS:SDZNY - Get Free Report) shares hit a new 52-week high on Tuesday . The company traded as high as $49.20 and last traded at $49.10, with a volume of 49059 shares traded. The stock had previously closed at $48.32.
Wall Street Analysts Forecast Growth
Several research firms have issued reports on SDZNY. BNP Paribas lowered shares of Sandoz Group from a "strong-buy" rating to a "hold" rating in a research report on Monday, December 2nd. UBS Group cut shares of Sandoz Group from a "strong-buy" rating to a "hold" rating in a report on Monday, February 3rd.
Get Our Latest Research Report on SDZNY
Sandoz Group Stock Performance
The company has a 50 day moving average price of $44.09 and a 200 day moving average price of $43.60.
About Sandoz Group
(
Get Free Report)
Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology, as well as bone disease.
Featured Articles
Before you consider Sandoz Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sandoz Group wasn't on the list.
While Sandoz Group currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
